Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Lack of Efficacy for Fluoxetine in PTSD: A Placebo Controlled Trial in Combat Veterans

Lack of Efficacy for Fluoxetine in PTSD: A Placebo Controlled Trial in Combat Veterans Background: Fluoxetine and placebo were studied in a population of combat veterans with severe, chronic PTSD. Methods: Twelve male veterans with PTSD were enrolled in a 12 week double-blind evaluation of fluoxetine and placebo. Mean fluoxetine dose at endpoint (week 12) was 48 mg/day with a range of 10 mg to 60 mg. Results: One fluoxetine patient responded (17%) and two of the six placebo patients responded (33%). Conclusions: Fluoxetine patients did not show a greater response than placebo patients in this small sample of male combat veterans with severe, chronic PTSD. Fluoxetine has displayed an efficacious response in controlled studies of patients with PTSD who were predominantly female, suffered civilian (noncombat) traumas, and were overall experiencing less severe PTSD. The reasons for the low response rate to fluoxetine in our study is unknown and will await further study examining variables other than symptoms that might influence outcome, such as gender, comorbidity, prior treatment history, trauma type, severity and chronicity. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Clinical Psychiatry Springer Journals

Lack of Efficacy for Fluoxetine in PTSD: A Placebo Controlled Trial in Combat Veterans

Download PDF
5 pages

Loading next page...
 
/lp/springer-journals/lack-of-efficacy-for-fluoxetine-in-ptsd-a-placebo-controlled-trial-in-aCaAQzZOxv
Publisher
Springer Journals
Copyright
Copyright © 2000 by American Academy of Clinical Psychiatrists
Subject
Medicine & Public Health; Neurology; Psychiatry; Psychopharmacology
ISSN
1040-1237
eISSN
1573-3238
DOI
10.1023/A:1009076231175
Publisher site
See Article on Publisher Site

Abstract

Background: Fluoxetine and placebo were studied in a population of combat veterans with severe, chronic PTSD. Methods: Twelve male veterans with PTSD were enrolled in a 12 week double-blind evaluation of fluoxetine and placebo. Mean fluoxetine dose at endpoint (week 12) was 48 mg/day with a range of 10 mg to 60 mg. Results: One fluoxetine patient responded (17%) and two of the six placebo patients responded (33%). Conclusions: Fluoxetine patients did not show a greater response than placebo patients in this small sample of male combat veterans with severe, chronic PTSD. Fluoxetine has displayed an efficacious response in controlled studies of patients with PTSD who were predominantly female, suffered civilian (noncombat) traumas, and were overall experiencing less severe PTSD. The reasons for the low response rate to fluoxetine in our study is unknown and will await further study examining variables other than symptoms that might influence outcome, such as gender, comorbidity, prior treatment history, trauma type, severity and chronicity.

Journal

Annals of Clinical Psychiatry – Springer Journals

Published: Oct 8, 2004

References

  • Posttraumatic Stress Disorder: A Comprehensive Text
    Schlenger, WE; Fairbank, JA; Jordan, K; Caddell, JM
  • Trauma: Prevalence, Impairment, Service Use, and Cost
    Solomon, SD; Davidson, JRT
  • Posttraumatic stress disorder in the national comorbidity study
    Kessler, RB; Bromet, E; Hughes, M; Nelson, CB
  • The role of serotonin in posttraumatic stress disorder: neurobiology and pharmacotherapy
    Connor, KM; Davidson, JRT
  • Dfenfluramine challenge in posttraumatic stress disorder
    Davis, LL; Clark, DM; Kramer, GL; Moeller, FG; Petty, F
  • Low platelet-poor plasma concentrations of serotonin in patients with combat-related posttraumatic stress disorder
    Spivak, B; Vered, Y; Graff, E; Blum, I; Mester, R; Weizman, A
  • The psychobiology of posttraumatic stress disorder
    van der Kolk, BA
  • Fluoxetine in posttraumatic stress disorder
    Davidson, JRT; Roth, S; Newman, E
  • An open trial of fluoxetine in the treatment of posttraumatic stress disorder (letter)
    McDougle, CJ; Southwick, SM; Charney, DS; St. James, RL
  • Biological Therapies for Posttraumatic Stress Disorder: An Overview
    Davidson, JRT
  • Current and future drug treatment for posttraumatic stress disorder patients
    Friedman, MJ
  • Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design
    Hertzberg, MA; Feldman, ME; Beckham, JC; Davidson, JRT
  • Open trial of nefazodone for combat-related posttraumatic stress disorder
    Hertzberg, MA; Feldman, ME; Beckham, JC; Moore, SD; Davidson, JRT
  • A Preliminary Study of Lamotrigine for the Treatment of Posttraumatic Stress Disorder
    Hertzberg, MA; Butterfield, MI; Feldman, ME; Beckham, JC; Sutherland, SM; Connor, KM; Davidson, JRT
  • Psychological Trauma. Review of Psychiatry
    Marshall, RD; Davidson, JRT; Yehuda, R
  • Treatment of posttraumatic stress disorder with amitriptyline and placebo
    Davidson, JRT; Kudler, HS; Smith, RD; Lipper, SL; Mahorney, SL; Hammett, EB; Saunders, WB; Cavenar, JO
  • Pharmacotherapy for posttraumatic stress disorder using phenalzine an imipramine
    Kosten, TR; Frank, JB; Dan, E; McDougole, CJ; Giller, EL
  • Pharmacotherapy of posttraumatic stress disorder with a novel psychotropic
    Katz, RJ; Lott, MH; Arbus, P; Crocq, L; Harlobsen, P; Ligjaerde, O; Lopez, G; Loughery, GC; Macfarlane, DJ; Nugent, D; Turner, SW; Weisaeth, L; Yule, W
  • Adouble-blind, randomized placebo-controlled multicenter study of brofaromine in the treatment of posttraumatic stress disorder
    Baker, DG; Diamond, BI; Gillette, G; Hamner, M; Katzelnick, D; Keller, T; Mellman, TA; Pontius, E; Rosenthal, M; Tucker, P.
  • Fluoxetine in posttraumatic stress disorder
    Connor, KM; Davidson, JRT; Sutherland, S; Malik, M; Tupler, L; Smith, R; Davison, R
  • Fluoxetine in posttraumatic stress disorder
    van der Kolk, BA; Dreyfuss, D; Michaels, M; Shera, D; Berkowitz, R; Fisler, R; Saxe, G
  • Fluvoxamine treatment for chronic PTSD: a pilot study
    DeBoer, M; Op den Velde, W; Flager, PJR; Hovens, JE; de Groen, JG; Van Duijn, H
  • Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder
    Marmar, CR; Schoenfeld, F; Weiss, DS; Metzler, T; Zatzick, D; Wu, R; Smiga, S; Tecott, L; Neylan, T
  • Open prospective trial of fluoxetine for posttraumatic stress disorder
    Nagy, LM; Morgan, CA; Southwick, SM; Charney, DS
  • Fluoxetine reduces explosiveness and elevates mood of Vietnam combat veterans with PTSD
    Shay, J
  • Structured interview for PTSD (SIP): psychometric validation for DSM-IV criteria
    Davidson, JRT; Malik, ML; Travers, J
  • Structured Clinical Interview for DSM_III-R-Patient Version (SCID-P)
    Spritzer, RL; Williams, JL; Gibbons, M
  • Clinical evaluation of a measure to assess combat exposure
    Keane, TM; Fairbank, JA; Cadddel, JM
  • Assessment of a New Self-Rating Scale for Post Traumatic Stress Disorder: The Davidson Trauma Scale
    Davidson, JRT; Book, SW; Colket, JT; Tupler, LA; Roth, S.; David, D; Hertzberg, MA; Mellman, T; Beckham, JC; Smith, RD; Davison, RM; Katz, R; Feldman, ME
  • The Anxiety Disease
    Sheehan, DV
  • Fluvoxamine in civilians with posttraumatic stress disorder (letter)
    Davidson, JRT; Weisler, RH; Malik, MA; Tupler, LA
  • Can the placebo be the cure?
    Enserink, M
  • Response characteristics to antidepressants and placebo in posttraumatic stress disorder
    Davidson, JRT; Malik, ML; Sutherland, SN
  • Nefazodone in posttraumatic stress disorder results of six open-label trials
    Hidalgo, R; Hertzberg, MA; Mellman, T.; Petty, F; Tucker, P; Weisler, R; Zisook, S; Chen, S; Churchill, E; Davidson, J
  • Psychopharmacology and Women: Sex, Gender and Hormones
  • Differences between males and females in rates of serotonin synthesis in human brain
    Nishizawa, S; Benkelfat, C; Young, SN.
  • Emotional Aftermath of the Persian Gulf War: Veterans, Families, Communities, and Nations
    Rosenheck, RA; Fontana, A
  • Psychotic Features and Illness Severity in Combat Veterans with Chronic PTSD
    Hamner, MB; Frueh, BC; Ulmer, HG; Arana, GW
  • Personality disorders in treatment-seeking combat veterans with posttraumatic stress disorder
    Southwick, SM; Yehuda, R; Giller, EL
  • Neuropsychiatric sequelae of cerebral malaria in Vietnam veterans
    Varney, NR; Roberts, RJ; Springer, JA; Connell, SK; Wood, PS
  • Effects of compensation-seeking on treatment outcomes among veterans with posttraumatic stress disorder
    Fontana, A; Rosenheck, R